Despite the efflux of the specific substrates being decreased in PD173074-treated cancer cells, the expression of the aforementioned ABC transporters remained constant, thereby suggesting the ability of this TKI to impair the function of P-gp and MRP7 [208,209]. This evidence concerns the gene ABCG2 and cancer.